Adapting and tailoring approaches to market access and pricing.

Pharma companies need be more agile and develop and enhance their core organizational capabilities to support market access and pricing in a proactive way throughout the life cycle of their products.

This includes, developing a deeper understanding of payer needs, using RWE to capture a product’s value, managing patient data effectively, and building trust with patients and payers.